DOCTOR FILES: When the Unknown Is Not So Bad
“DOCTOR FILES: When the Unknown Is Not So Bad” – Los Angeles Times
“DOCTOR FILES: When the Unknown Is Not So Bad” – Los Angeles Times
Here is a link to a story from one of my favorite reporters, Rebecca Plevin from KPCC radio in California. She uncovered a startup company that tries to help people shop for healthcare services, by letting them name their price and seeing if any healthcare providers are game: Shopping for things like hotel reservations is…
It would have been a difficult ending under the best of circumstances. Composing what would be his last opera, Giacomo Puccini was struggling to humanize Turandot, daughter of the Emperor and a woman of mesmerizing beauty. Early in the opera, she had cruelly disposed of a series of want-to-be suitors, beheading some and torturing others,…
The oncologist had prescribed Xgeva hoping it would strengthen her bones while also delaying the progression of Angela Kahn’s breast cancer. But Kahn (a pseudonym) couldn’t get over the price of the drug. Before the oncologist had a chance to ask how she was feeling, she blurted out that the medication cost “$15,000 a shot.”…
It is hard to make money treating rare diseases. There simply aren’t enough customers to generate many profits. That’s why the U.S. government passed the Orphan Drug Act in 1983, a law which created a series of incentives to encourage drug companies to develop treatments for rare or “orphan” diseases – conditions affecting less than…
Sometimes it is hard for hospitals to provide expensive care to poor patients. When a low-income patient needs $20,000 of chemotherapy, a hospital loses money if that patient cannot pay for the medicine, or pays through Medicaid, with its relatively stingy reimbursement. Fortunately, the federal government created a program for hospitals that care for a…